2026

Case Study

Protein Ligand MD: Dynamic Binding Validation for Kinase Inhibitor Lead Optimization

Evaluating protein-ligand MD simulation quality and MM-GBSA binding energy rank–ordering across three clinically relevant kinase targets for lead optimization in drug discovery

If the PDF doesn’t display, open it in a new tab or download it.

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026

The Final Operating System of Pharma.

909.267.0577

3680 Wilshire Blvd
P04-1343 Los Angeles
CA 90010

Revilico 2026